112 related articles for article (PubMed ID: 11032949)
1. Immunohistochemical study of fatty acid synthase in ovarian neoplasms.
Alò PL; Visca P; Framarino ML; Botti C; Monaco S; Sebastiani V; Serpieri DE; Di Tondo U
Oncol Rep; 2000; 7(6):1383-8. PubMed ID: 11032949
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer.
Shurbaji MS; Kalbfleisch JH; Thurmond TS
Hum Pathol; 1996 Sep; 27(9):917-21. PubMed ID: 8816886
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Gansler TS; Hardman W; Hunt DA; Schaffel S; Hennigar RA
Hum Pathol; 1997 Jun; 28(6):686-92. PubMed ID: 9191002
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
Sebastiani V; Visca P; Botti C; Santeusanio G; Galati GM; Piccini V; Capezzone de Joannon B; Di Tondo U; Alo PL
Gynecol Oncol; 2004 Jan; 92(1):101-5. PubMed ID: 14751145
[TBL] [Abstract][Full Text] [Related]
6. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
8. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
9. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
10. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Kuşku Cabuk F; Yığıt S; Demır L; Cakalağaoğlu F; Tarhan O
Turk Patoloji Derg; 2014; 30(1):30-7. PubMed ID: 24448704
[TBL] [Abstract][Full Text] [Related]
11. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients.
Alo' PL; Visca P; Marci A; Mangoni A; Botti C; Di Tondo U
Cancer; 1996 Feb; 77(3):474-82. PubMed ID: 8630954
[TBL] [Abstract][Full Text] [Related]
12. Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer.
Hanker LC; Karn T; Holtrich U; Gätje R; Rody A; Heinrich T; Ruckhäberle E; Engels K
Int J Gynecol Pathol; 2013 May; 32(3):249-57. PubMed ID: 23518908
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of iNOS in epithelial ovarian cancer.
Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
[TBL] [Abstract][Full Text] [Related]
14. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase expression in melanoma.
Innocenzi D; Alò PL; Balzani A; Sebastiani V; Silipo V; La Torre G; Ricciardi G; Bosman C; Calvieri S
J Cutan Pathol; 2003 Jan; 30(1):23-8. PubMed ID: 12534800
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer.
Swinnen JV; Roskams T; Joniau S; Van Poppel H; Oyen R; Baert L; Heyns W; Verhoeven G
Int J Cancer; 2002 Mar; 98(1):19-22. PubMed ID: 11857379
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas.
Alò PL; Visca P; Trombetta G; Mangoni A; Lenti L; Monaco S; Botti C; Serpieri DE; Di Tondo U
Tumori; 1999; 85(1):35-40. PubMed ID: 10228495
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-1 in epithelial ovarian cancer: a clinicopathological study.
Khunnarong J; Tangjitgamol S; Manusirivithaya S; Suekwattana P; Leelahakorn S
Asian Pac J Cancer Prev; 2008; 9(4):757-62. PubMed ID: 19271346
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance.
Ayhan A; Ertunc D; Tok EC; Ayhan A
Int J Gynecol Cancer; 2005; 15(4):618-23. PubMed ID: 16014115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
